3 Wall Street Darlings We Advise Handling with Care

Wall Street Optimism vs. Reality: A Closer Look at Analyst Ratings

Many Wall Street analysts are highly optimistic about the stocks discussed below, projecting considerable upside based on their price targets. However, it's important to note that sell recommendations are rare, as analysts' firms often have business relationships with the companies they cover.

Unlike major investment banks, StockStory was created to offer unbiased insights, helping investors identify which companies truly deserve attention. With that in mind, let's examine three stocks where Wall Street's projections may not align with the underlying fundamentals, as well as highlight some more promising alternatives.

DocuSign (DOCU)

Analyst Price Target: $86.50 (suggesting a 33.8% potential gain)

DocuSign (NASDAQ: DOCU) has become synonymous with digital agreements, enabling over a billion users worldwide to electronically prepare, sign, and manage contracts and documents through its platform.

Concerns About DocuSign

• Customer reluctance to commit to long-term contracts has resulted in sluggish annual recurring revenue growth, averaging just 8.4% over the past year.
• Projected sales growth of 6.7% for the coming year points to uncertain demand.
• While operating profits have improved, this is largely due to better cost management and increased efficiency.

Currently, DocuSign trades at $64.65 per share, reflecting a forward price-to-sales ratio of 4.

Quanex (NX)

Analyst Price Target: $28 (implying a 78.1% potential return)

Quanex (NYSE: NX) began in the seamless tube sector and now manufactures a variety of building products, including components for windows, doors, kitchens, and bathroom cabinets.

Why We're Hesitant on Quanex

• Operational efficiency has declined, with operating margins dropping by 18.2 percentage points over the past five years.
• Despite revenue growth, incremental sales have been less profitable, as earnings per share have decreased by 8.5% annually over the last two years.
• Returns on capital have weakened further, highlighting ineffective management decisions regarding investments.

Quanex shares are priced at $15.73, equating to a forward P/E ratio of 7.3.

First Financial Bankshares (FFIN)

Analyst Price Target: $36.40 (projecting an 18.3% upside)

First Financial Bankshares (NASDAQ: FFIN), with a history dating back to 1890, operates more than 70 branches across Texas, offering commercial banking, trust, and wealth management services throughout the state.

Reasons for Caution with FFIN

• Revenue growth has averaged just 5.8% annually over the past five years, trailing behind industry peers.
• Net interest income has grown at a modest 7.7% per year, indicating weaker demand compared to competitors.
• Earnings per share have increased by only 5.3% annually, underperforming other banks in the sector.

At $30.77 per share, FFIN is valued at 2.3 times its forward price-to-book ratio.

Our Preferred Stock Picks

Relying on just a handful of stocks can leave your portfolio vulnerable. Now is the time to secure high-quality investments before the market broadens and opportunities diminish.

Don't wait for the next market downturn. Explore our Top 9 Market-Beating Stocks—a carefully selected group of high-quality companies that have delivered a 244% return over the past five years (as of June 30, 2025).

Our 2020 selections featured standout performers like Nvidia, which soared 1,326% from June 2020 to June 2025, as well as lesser-known names such as Kadant, which achieved a 351% five-year return. Start your search for the next breakout stock with StockStory—it's free.